Tumor necrosis factor alpha polymorphism in heart failure/cardiomyopathy (Q35980608)

11 August 2017

1 reference

title

Tumor necrosis factor alpha polymorphism in heart failure/cardiomyopathy (English)

1 reference

11 August 2017

1 reference

Lou Vadlamani

1

1 reference

11 August 2017

Srinivas Iyengar

series ordinal

2

1 reference

11 August 2017

publication date

1 November 2004

1 reference

11 August 2017

published in

Congestive Heart Failure

1 reference

11 August 2017

volume

10

1 reference

11 August 2017

issue

6

1 reference

11 August 2017

page(s)

289-292

1 reference

Synergistic polymorphisms of beta1- and alpha2C-adrenergic receptors and the risk of congestive heart failure

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.02020.X

Angiotensin-converting enzyme genotype modulates pulmonary function and exercise capacity in treated patients with congestive stable heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.02020.X

Inflammatory gene polymorphisms and ischaemic heart disease: review of population association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.02020.X

Tumour necrosis factor alpha and the cardiovascular system: its role in cardiac allograft rejection and heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.02020.X

Tumor necrosis factor-alpha (TNF-alpha) plays a protective role in acute viralmyocarditis in mice: A study using mice lacking TNF-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.02020.X

Randomised investigation of effects of pentoxifylline on left-ventricular performance in idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.02020.X

Beneficial effects of pentoxifylline in patients with idiopathic dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitors and carvedilol: results of a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.02020.X

Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.02020.X

Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.02020.X

Tumour necrosis factor alpha gene polymorphism: a predisposing factor to non-ischaemic myocardial dysfunction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.02020.X

Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.02020.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.02020.X

Comparative analysis of the genetic associations of HLA-DR3 and tumour necrosis factor alpha with human IDDM

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.02020.X

10.1111/J.1527-5299.2004.02020.X

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference